image
Halozyme Therapeutics, Inc. HALO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 45.65
-15.4 %
$ 5.81 B
Market Cap
16.42
P/E
INCOME STATEMENT
829 M REVENUE
25.62%
Growth Rates
1Year 25.62%
3Years 45.79%
5Years 40.43%
7Years 28.08%
10Years 31.22%
338 M OPERATING INCOME
26.18%
Growth Rates
1Year 26.18%
3Years 32.76%
5Years 47.02%
7Years 29.35%
10Years 20.01%
282 M NET INCOME
39.31%
Growth Rates
1Year 39.31%
3Years 29.69%
5Years 40.66%
7Years 24.87%
10Years 18.31%
EFFICIENCY
Earnings Waterfall Halozyme Therapeutics, Inc.
image
Revenue 829 M
Cost Of Revenue 192 M
Gross Profit 637 M
Operating Expenses 299 M
Operating Income 338 M
Other Expenses 56 M
Net Income 282 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001
REVENUE
Revenue 829.3 660.1 443.3 267.6 196.0 151.9 316.6 146.7 135.1 75.3 54.8 42.3 56.1 13.6 13.7 8.8 3.8 1.0 0.1 0 25.7 K 87.8 K 24.7 K
GROSS PROFIT
Cost Of Revenue 192.4 139.3 81.4 43.4 45.5 10.1 31.2 33.2 29.2 22.7 6.2 1.1 0.3 1.0 0.3 0.3 0.2 0.4 52 K 0 27 K 49.7 K 15.9 K
Gross Profit 636.9 520.8 361.9 224.2 150.4 141.7 285.5 113.5 105.8 52.6 48.6 41.2 55.8 12.6 13.4 8.4 3.6 0.5 75.2 K 0 1.3 K 38.1 K 8.83 K
OPERATING INCOME
Operating Expenses 299.3 253.3 86.0 80.0 218.1 211.1 204.5 196.7 133.3 115.6 129.0 94.9 75.7 66.9 71.8 58.9 31.7 16.1 13.6 9.1 77.8 K 77.5 K 48.5 K
Selling, General and Administrative Expenses 149.2 143.5 50.3 45.7 77.3 60.8 53.8 45.9 40.0 35.9 32.3 24.8 18.1 15.1 15.2 14.6 11.2 6.9 3.4 2.6 77.8 K 350 48.5 K
Research and Development Expenses 76.4 66.6 35.7 34.2 140.8 150.3 150.6 150.8 93.2 79.7 96.6 70.0 57.6 51.8 56.6 44.2 20.6 9.2 10.2 6.5 0 0 0
Operating Income 337.6 267.5 275.9 144.3 (67.6) (69.3) 81.0 (83.2) (27.5) (63.0) (80.4) (53.6) (19.8) (54.3) (58.5) (50.4) (28.2) (15.6) (13.6) (9.1) 79.1 K 39.4 K 39.7 K
PRE-TAX INCOME
Interest Income Expense 18.8 16.9 7.5 20.4 11.6 18.0 22.0 20.0 5.2 5.6 3.3 0 0 0 3.01 K 0 0 0 0 0 0 0 0
Total Other Income 10.8 (18.6) (27.4) (15.0) (4.6) (10.5) (19.4) (18.7) (4.8) (5.3) (3.0) 73 K 69.1 K 1.0 97.7 K 1.7 4.3 0.8 0.3 3.53 K 0 25.1 K 54
Pre-Tax Income 348.3 248.9 248.5 129.3 (72.3) (79.8) 61.6 (101.9) (32.2) (68.4) (83.5) (53.6) (19 769.9) (53.2) (58.4) (48.7) 0 0 (13.3) (9.1) 0 64.5 K 39.7 K
NET INCOME
Tax Provision 66.7 46.8 (154.2) 0.2 11 K 0.5 (1.4) 1.2 3.5 3.8 2.0 (1.1) (1.2) (1.0) 0 63 K (4.3) (0.8) (0.3) 3.53 K 79.1 K 800 0
Net Income 281.6 202.1 402.7 129.1 (72.2) (80.3) 63.0 (103.0) (32.2) (68.4) (83.5) (53.6) (19.8) (53.2) (58.4) (48.7) (23.9) (14.8) (13.3) (9.1) 79.1 K 65.3 K 39.7 K
EPS 2.13 1.48 2.86 0.95 0.5 0.56 0.46 0.81 0.25 0.56 0.74 0.48 0.19 0.56 0.67 0.61 0.32 0.24 0.26 0.26 0.0116 0.0142 0.0331